Pharma — Juni 2025
-
Lundbeck får tildelt særstatus til lægemiddelkandidat i EU og USA https://proinvestor.com/investornyt/1332383/lundbeck-far-tildelt-saerstatus-til-laegemiddelkandidat-i-eu-og-usa
-
ALK lancerer adrenalinspray i Tyskland https://proinvestor.com/investornyt/1333335/alk-lancerer-adrenalinspray-i-tyskland
-
Trump Vows To Cut 'The Best Deal' On Drug https://www.investors.com/news/technology/drug-prices-most-favored-nation-biotech-stocks/
-
Innovent's Lilly-partnered obesity asset wins approval in China https://firstwordpharma.com/story/5976911
-
FDA eliminates barrier to CAR-T accessibility https://firstwordpharma.com/story/5976913
-
Low RSV infection rates scupper Gilead's obeldesivir studies https://firstwordpharma.com/story/5976665
kunne være rart Lundbecks aktie gad reagere på de positive data syntes godt nok ikke den rigtig kommer videre opad 
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind